DNS ACCOUNTANTS LTD

Financial Health Assessment: DNS Accountants Ltd

1. Financial Health Score: B- While the company exhibits a strong and growing equity base with robust profitability, it is currently suffering from acute short-term liquidity stress. The dramatic shift into negative working capital and the severe depletion of cash reserves indicate that the business is expanding aggressively, possibly through debt, at a pace that is outstripping its immediate capacity to pay short-term obligations. This imbalance requires urgent remedial care.

2. Key Vital Signs * Profitability (Healthy Pulse): The company’s profit for the year surged from £426,090 in 2024 to £688,745 in 2025. This represents a 61% increase in net income, indicating that the core business operations are highly viable and generating excellent returns. * Net Assets & Equity (Strong Bone Density): Total net assets grew from £3,099,202 to £3,787,947. Shareholders' funds are robust at £2,802,520, showing that the company is successfully retaining wealth and building a solid structural foundation. * Working Capital (Dangerously Low Blood Pressure): Net current assets have plummeted from a positive £2,367,709 in 2024 to a negative £(1,808,020) in 2025. This is a critical symptom of financial distress; the company's current liabilities heavily outweigh its current assets, meaning it could struggle to cover its immediate debts if they were called in. * Cash Reserves (Depleted Immune System): Cash at bank has dropped drastically from £1,125,065 to just £336,414. For a company with £4.3 million in current liabilities, this low level of cash creates a severe vulnerability to unexpected shocks. * Debt Burden (Elevated Cholesterol): Current liabilities have surged from £1,353,722 to £4,326,830, and long-term liabilities have ballooned from £37,500 to £1,716,633. This massive increase in creditor obligations is the primary cause of the liquidity strain.

3. Diagnosis The patient is experiencing "hyper-growth syndrome." The underlying business is fundamentally healthy—revenues are clearly growing, and profitability is excellent. However, the balance sheet tells a story of aggressive expansion.

The most glaring symptom is the £6.6 million leap in fixed investments (up from £51,519 to £6,710,587). This acquisition or investment splurge was funded primarily by taking on massive short-term liabilities, resulting in a cash drain and negative working capital. Essentially, the company is trying to run a marathon while carrying a heavy backpack of short-term debt. While the long-term equity is secure, the immediate circulatory system (cash flow and working capital) is severely restricted. If trade creditors demand payment or revenue stalls temporarily, the company could face a liquidity heart attack despite being fundamentally profitable.

4. Recommendations To restore financial wellness and ensure sustainable growth, the following treatment plan is recommended: * Liquidity Infusion (Refinancing): The most urgent priority is restructuring the debt. Moving a significant portion of the £4.3M in current liabilities to long-term financing will immediately cure the negative working capital and relieve the pressure on cash reserves. * Accelerate Receivables (Improve Circulation): With £2.18M sitting in debtors, the company must ensure it is collecting cash promptly. Tightening credit terms and chasing overdue invoices will help replenish the depleted cash reserves. * Pause Aggressive Expansion (Rest and Recovery): While the recent investments may yield excellent future returns, the business needs time to digest this growth. Halting further acquisition spending until cash flows stabilize and current debts are serviced is essential to avoid over-leveraging. * Cash Flow Forecasting (Continuous Monitoring): Implement a rigorous 13-week rolling cash flow forecast. With such a thin cash margin, management must know exactly when cash peaks and troughs will occur to prevent a sudden default on creditor obligations.